phosphine has been researched along with Cancer of Prostate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arrowsmith, RL; Benny, PD; Botchway, SW; Clegg, W; Davies, LH; Ge, H; Harrington, RW; Higham, LJ; Kasten, BB; Pascu, SI | 1 |
Duatti, A; Faintuch, BL; Faintuch, S; Muramoto, E; Smith, CJ; Teodoro, R | 1 |
2 other study(ies) available for phosphine and Cancer of Prostate
Article | Year |
---|---|
Re and (99m)Tc complexes of BodP3--multi-modality imaging probes.
Topics: Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; Fluorescent Dyes; Humans; Male; Models, Molecular; Multimodal Imaging; Optical Imaging; Phosphines; Prostatic Neoplasms; Rhenium; Technetium; Tomography, Emission-Computed, Single-Photon | 2014 |
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Topics: Animals; Bombesin; Cell Line, Tumor; Cysteine; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Hydrazines; Hydrophobic and Hydrophilic Interactions; Isotope Labeling; Male; Metabolic Clearance Rate; Mice; Niacinamide; Nitrogen Compounds; Organotechnetium Compounds; Pancreas; Phosphines; Prostate; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution | 2008 |